These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 3542907)

  • 21. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
    Kabela E; Michaels DC; Felice EL
    Arch Inst Cardiol Mex; 1979; 49(5):892-907. PubMed ID: 398199
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inotropic agents with calcium-sensitizing properties: clinical and hemodynamic effects of pimobendan.
    Kubo SH
    Coron Artery Dis; 1994 Feb; 5(2):119-26. PubMed ID: 8180743
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of heart failure in children].
    Pipitone S; Manetti A
    G Ital Cardiol; 1995 Nov; 25(11):1485-90. PubMed ID: 8682250
    [No Abstract]   [Full Text] [Related]  

  • 26. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? II. Protagonist's viewpoint.
    Packer M
    J Am Coll Cardiol; 1988 Aug; 12(2):562-6. PubMed ID: 3392349
    [No Abstract]   [Full Text] [Related]  

  • 27. [Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests].
    Sfrisi C; Cocco G
    Clin Ter; 1984 Oct; 111(2):159-67. PubMed ID: 6239739
    [No Abstract]   [Full Text] [Related]  

  • 28. [Heart insufficiency: current aspects of physiopathology and therapy].
    Bolte HD
    Med Klin; 1981 Nov; 76(24):664-71. PubMed ID: 7311926
    [No Abstract]   [Full Text] [Related]  

  • 29. Milrinone: a positive inotropic vasodilator.
    Colucci WS; Jaski BE; Fifer MA; Wright RF; Braunwald E
    Trans Assoc Am Physicians; 1984; 97():124-33. PubMed ID: 6535335
    [No Abstract]   [Full Text] [Related]  

  • 30. Present and future trends in research and clinical applications of inodilators.
    Cargnelli G; Piovan D; Bova S; Padrini R; Ferrari M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S124-32. PubMed ID: 2483438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inotropic agents in advanced and refractory heart failure].
    Mangiavacchi M; Gronda E
    Ital Heart J Suppl; 2003 Jan; 4(1):3-7. PubMed ID: 12690928
    [No Abstract]   [Full Text] [Related]  

  • 32. The new inotropic phosphodiesterase inhibitors.
    el Allaf D; D'Orio V; Carlier J
    Arch Int Physiol Biochim; 1984 Nov; 92(4):S69-79. PubMed ID: 6085243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inotropic drugs in the treatment of heart failure.
    Scholz H
    Hosp Pract (Off Ed); 1984 May; 19(5):57-67, 70-1. PubMed ID: 6143760
    [No Abstract]   [Full Text] [Related]  

  • 34. When should we use nitrates in congestive heart failure?
    Vizzardi E; Bonadei I; Rovetta R; D'Aloia A; Quinzani F; Curnis A; Dei Cas L
    Cardiovasc Ther; 2013 Feb; 31(1):27-31. PubMed ID: 22953723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heart failure].
    Erdmann E
    Internist (Berl); 1991 Apr; 32(4):W25-36. PubMed ID: 1856058
    [No Abstract]   [Full Text] [Related]  

  • 36. Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure.
    von der Leyen H
    Klin Wochenschr; 1989 Jun; 67(12):605-15. PubMed ID: 2671473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New drugs with positive inotropic action].
    Bijak A; Czołpiński T
    Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute heart failure in myocardial infarction: principles of treatment.
    Perret C
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S26-9. PubMed ID: 2403511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of heart failure with enoximone, a new phosphodiesterase inhibitor. Düsseldorf, Federal Republic of Germany. September 25-27, 1987. Proceedings.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S1-S83. PubMed ID: 2480479
    [No Abstract]   [Full Text] [Related]  

  • 40. New positive inotropic agents in the treatment of left ventricular dysfunction.
    De Luca L; Proietti P; Palombaro GL; Battagliese A; Celotto A; Bucciarelli Ducci C; Fedele F
    Ital Heart J; 2004 Jun; 5 Suppl 6():63S-67S. PubMed ID: 15185917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.